SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001587221-22-000025
Filing Date
2022-04-29
Accepted
2022-04-29 16:01:10
Documents
18
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A zsan-20211231.htm   iXBRL 10-K/A 557654
2 EX-10.44 exhibit1044zosano-march202.htm EX-10.44 55376
3 EX-31.3 exhibit313fy2110ka.htm EX-31.3 4378
4 EX-31.4 exhibit314fy2110ka.htm EX-31.4 4674
8 image_0.jpg GRAPHIC 140
9 image_1.jpg GRAPHIC 96
  Complete submission text file 0001587221-22-000025.txt   920736

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zsan-20211231.xsd EX-101.SCH 2560
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zsan-20211231_lab.xml EX-101.LAB 40317
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zsan-20211231_pre.xml EX-101.PRE 21139
12 EXTRACTED XBRL INSTANCE DOCUMENT zsan-20211231_htm.xml XML 23826
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36570 | Film No.: 22875030
SIC: 2834 Pharmaceutical Preparations